AMYLIN PHARMACEUTICALS INC Retained Earnings
AMYLIN PHARMACEUTICALS INC had Retained Earnings of -$2.82 billion as of 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2012-08-03
- 2012-06-30: Retained Earnings (Accumulated Deficit) -$2.82B.
- 2012-03-31: Retained Earnings (Accumulated Deficit) -$2.74B.
- 2011-12-31: Retained Earnings (Accumulated Deficit) -$2.64B.
- 2011-09-30: Retained Earnings (Accumulated Deficit) -$2.18B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-06-30 | -$2.82B 10-Q · filed 2012-08-03 |
| 2012-03-31 | -$2.74B 10-Q · filed 2012-05-07 |
| 2011-12-31 | -$2.64B 10-Q · filed 2012-08-03 |
| 2011-09-30 | -$2.18B 10-Q · filed 2011-10-28 |
| 2011-06-30 | -$2.17B 10-Q · filed 2011-08-08 |
| 2011-03-31 | -$2.14B 10-Q · filed 2011-05-05 |
| 2010-12-31 | -$2.10B 10-K · filed 2012-02-22 |
| 2010-09-30 | -$2.08B 10-Q · filed 2010-11-08 |
| 2010-06-30 | -$2.03B 10-Q · filed 2010-08-05 |
| 2009-12-31 | -$1.95B 10-K · filed 2011-02-25 |